CMBA
ACLS icon

C.M. Bidwell & Associates’s Axcelis ACLS Stock Holding History

C.M. Bidwell & Associates’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-209
Closed -$27.1K – 481
2023
Q4 		$27.1K Hold
209
– – 0.02% 254
2023
Q3 		$34.1K Buy
+209
New +$36.8K 0.03% 314

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

C.M. Bidwell & Associates's ACLS Position: Q1 2024 in Review

C.M. Bidwell & Associates sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 209 shares — an estimated $27.1K sold.

C.M. Bidwell & Associates first reported a position in ACLS in Q3 2023 and held it in 2 quarters. The position peaked at $34.1K in Q3 2023. 386 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • C.M. Bidwell & Associates reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 209 Axcelis shares in Q1 2024, an estimated $27.1K.
  • C.M. Bidwell & Associates first reported a position in Axcelis in Q3 2023 and held it in 2 quarters.
  • C.M. Bidwell & Associates's Axcelis position peaked at $34.1K in Q3 2023.
  • 386 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2024, filed 14 May 2024.